Login / Signup

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect.

José Luis López-CamposAlberto Fernández-VillarAlberto Ruano-Raviña
Published in: American journal of respiratory and critical care medicine (2021)
Keyphrases
  • chronic obstructive pulmonary disease
  • cardiovascular events
  • lung function
  • risk factors
  • type diabetes
  • stem cells
  • cardiovascular disease
  • bone marrow
  • cystic fibrosis
  • mesenchymal stem cells
  • replacement therapy